Concourse Financial Group Securities, Inc. Lexaria Bioscience Corp. Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LEXX
# of Institutions
27Shares Held
1.47MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY460KShares$676,2000.01% of portfolio
-
Invenomic Capital Management LP Boston, MA411KShares$603,7740.04% of portfolio
-
Geode Capital Management, LLC Boston, MA167KShares$245,0180.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA127KShares$187,3260.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL60.6KShares$89,1400.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $8.75M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...